Ally Bridge Group

Ally Bridge Group as of March 31, 2023

Portfolio Holdings for Ally Bridge Group

Ally Bridge Group holds 18 positions in its portfolio as reported in the March 2023 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Verona Pharma Sponsored Ads (VRNA) 12.8 $9.8M 488k 20.08
Xenon Pharmaceuticals (XENE) 12.5 $9.6M 267k 35.79
Bellus Health Com New 10.7 $8.1M 1.1M 7.20
Cytokinetics Com New (CYTK) 10.3 $7.9M 223k 35.19
Madrigal Pharmaceuticals (MDGL) 9.4 $7.2M 30k 242.26
Iveric Bio 8.1 $6.2M 255k 24.33
Merus N V (MRUS) 6.7 $5.1M 276k 18.40
Mersana Therapeutics (MRSN) 6.4 $4.9M 1.2M 4.11
Jasper Therapeutics 6.0 $4.6M 2.5M 1.81
Sarepta Therapeutics (SRPT) 3.8 $2.9M 21k 137.83
Cti Biopharma 3.0 $2.3M 550k 4.20
Medavail Holdings Ord 2.2 $1.7M 5.9M 0.29
Mdxhealth Sa Sponsored Ads 2.1 $1.6M 500k 3.24
Moonlake Immunotherapeutics Class A Ord (MLTX) 2.0 $1.6M 73k 21.39
Rapid Micro Biosystems Class A Com (RPID) 1.2 $917k 700k 1.31
Essa Pharma Com New (EPIX) 0.9 $703k 237k 2.97
Kinnate Biopharma 0.9 $684k 109k 6.25
Syros Pharmaceuticals Com New (SYRS) 0.9 $665k 249k 2.67